Latest Liquidity News

Prospech Limited has announced a 2-for-7 renounceable rights issue to raise up to $1.6 million, featuring attaching options exercisable at 4 cents. Directors are backing the raise, which will fund rare earth metallurgical work and exploration in Finland and Slovakia.

The ASX has suspended trading in six companies starting 1 September 2025 due to late lodgement of mandatory periodic reports. The suspension may be lifted quickly if reports are filed promptly.

Corporate Travel Management Limited’s shares remain suspended on the ASX as the company delays lodging its Preliminary Final Report amid ongoing financial restatement concerns.

Mayfield Childcare Limited reported a modest underlying EBITDA loss for the first half of 2025 amid occupancy challenges and acquisition underperformance. The company’s operational overhaul and targeted investments signal a cautious but hopeful recovery trajectory.

Pro-Pac Packaging is progressing a strategic review involving potential asset sales and liquidity support, with ASX trading suspension imminent pending financial disclosures.

Evolution Energy Minerals Limited’s EV1O securities have been suspended from ASX quotation due to non-compliance with a key listing rule, raising questions about the company’s regulatory standing.

Sayona Mining has completed its merger with Piedmont Lithium, creating a new lithium entity with equal ownership and a refreshed board. The combined company, soon to be renamed Elevra Lithium, aims to strengthen its position in the global energy transition.

Fat Prophets Global Contrarian Fund Ltd has reported a robust 56% increase in net profit for the year ended 30 June 2025, driven by strong investment returns and a leveraged global equity portfolio. The company also declared a fully franked special dividend, reflecting confidence in its ongoing performance.

PT Aneka Tambang Tbk (ANTAM) reported a remarkable 240% surge in net profit for the half year ended June 30, 2025, driven by robust gold and nickel sales amid a challenging mining sector.

Opthea Limited reported a 26% reduction in net loss for FY2025 despite discontinuing its wet AMD drug after failed Phase III trials. The company settled its Development Funding Agreement with investors, securing liquidity and planning a strategic pivot.

Botanix Pharmaceuticals posted a sharp revenue increase driven by its new hyperhidrosis treatment Sofdra, yet reported a substantial net loss reflecting heavy investment in commercialisation. The company’s strong cash position underpins its path to profitability.

FirstWave Cloud Technology reports a significant reduction in losses for FY25, driven by operational restructuring and new AI initiatives, while setting sights on Latin American expansion.